U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
POLY-L-LYSINE (30000-70000 MW)
0A1V8JTU2M
Possibly Marketed Outside US
First approved in 2022
General
Record Details
Names
5
Identifiers
7
Display Structure
Characteristic Attributes
1
POLY-L-LYSINE (30000-70000 MW)
0A1V8JTU2M
Possibly Marketed Outside US
First approved in 2022
General
Approval Year
2022
358
Record Details
Substance Class
Polymer
Record UNII
0A1V8JTU2M
Record Status
Validated (UNII)
Record Version
12
11
10
9
8
7
6
5
4
3
2
1
Names
5
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
POLY-L-LYSINE (30000-70000 MW)
Common Name
English
POLY(.ALPHA.-LYSINE) (30000-70000 MW)
Common Name
English
Polylysine [INCI]
Common Name
English
POLYLYSINE (30000-70000 MW)
Common Name
English
POLY(IMINO((1S)-1-(4-AMINOBUTYL)-2-OXO-1,2-ETHANEDIYL)) (30000-70000 MW)
Common Name
English
Showing 1 to 5 of 5 entries
Previous
1
Next
Identifiers
7
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
RXCUI
2380370
PRIMARY
EPA CompTox
DTXSID20958978
PRIMARY
CAS
25104-18-1
ALTERNATIVE
FDA UNII
0A1V8JTU2M
PRIMARY
WIKIPEDIA
Polylysine
PRIMARY
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Display Structure
Export Data
Characteristic Attributes
1
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
MOL_WEIGHT:NUMBER AVERAGE
CHEMICAL
[30000 to 70000] DALTONS (average)
Showing 1 to 1 of 1 entries
Previous
1
Next